{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T01:09:38Z","timestamp":1783040978842,"version":"3.54.6"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-02814-7","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T04:37:06Z","timestamp":1749530226000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Modulation of copper homeostasis and cuproptosis by PDHA1 in acute myeloid leukemia"],"prefix":"10.1007","volume":"16","author":[{"given":"Tianping","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxiu","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaohong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haipeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"issue":"3","key":"2814_CR1","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/ajh.26822","volume":"98","author":"S Shimony","year":"2023","unstructured":"Shimony S, Stahl M, Stone RM. Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management. Am J Hematol. 2023;98(3):502\u201326.","journal-title":"Am J Hematol"},{"issue":"1","key":"2814_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13045-023-01424-6","volume":"16","author":"RS Bhansali","year":"2023","unstructured":"Bhansali RS, Pratz KW, Lai C. Recent advances in targeted therapies in acute myeloid leukemia. J Hematol Oncol. 2023;16(1):29.","journal-title":"J Hematol Oncol"},{"key":"2814_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2026","volume":"375","author":"LF Newell","year":"2021","unstructured":"Newell LF, Cook RJ. Advances in acute myeloid leukemia. BMJ. 2021;375: n2026.","journal-title":"BMJ"},{"issue":"1","key":"2814_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.blre.2016.08.005","volume":"31","author":"J Prada-Arismendy","year":"2017","unstructured":"Prada-Arismendy J, Arroyave JC, R\u00f6thlisberger S. Molecular biomarkers in acute myeloid leukemia. Blood Rev. 2017;31(1):63\u201376.","journal-title":"Blood Rev"},{"issue":"6586","key":"2814_CR5","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov P, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022;375(6586):1254\u201361.","journal-title":"Science"},{"issue":"1","key":"2814_CR6","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41392-022-01229-y","volume":"7","author":"L Chen","year":"2022","unstructured":"Chen L, Min J, Wang F. Copper homeostasis and cuproptosis in health and disease. Signal Transduct Target Ther. 2022;7(1):378.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"2814_CR7","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.21037\/tcr-22-2526","volume":"12","author":"T Zhang","year":"2023","unstructured":"Zhang T, Liao D, Hu Y. Cuproptosis-related lncRNAs forecast the prognosis of acute myeloid leukemia. Transl Cancer Res. 2023;12(5):1175\u201395.","journal-title":"Transl Cancer Res"},{"key":"2814_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122223","volume":"334","author":"Z Tian","year":"2023","unstructured":"Tian Z, et al. Copper homeostasis and cuproptosis in mitochondria. Life Sci. 2023;334: 122223.","journal-title":"Life Sci"},{"issue":"6","key":"2814_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.189013","volume":"1878","author":"X Liu","year":"2023","unstructured":"Liu X, et al. Cuproptosis and cuproptosis-related genes: Emerging potential therapeutic targets in breast cancer. Biochim Biophys Acta Rev Cancer. 2023;1878(6): 189013.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2814_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114830","volume":"163","author":"D Wang","year":"2023","unstructured":"Wang D, et al. The molecular mechanisms of cuproptosis and its relevance to cardiovascular disease. Biomed Pharmacother. 2023;163: 114830.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"2814_CR11","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1002\/med.22025","volume":"44","author":"J Wu","year":"2024","unstructured":"Wu J, et al. Cuproptosis: Mechanism, role, and advances in urological malignancies. Med Res Rev. 2024;44(4):1662\u201382.","journal-title":"Med Res Rev"},{"issue":"7","key":"2814_CR12","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41419-023-05952-4","volume":"14","author":"S An","year":"2023","unstructured":"An S, et al. PDHA1 hyperacetylation-mediated lactate overproduction promotes sepsis-induced acute kidney injury via Fis1 lactylation. Cell Death Dis. 2023;14(7):457.","journal-title":"Cell Death Dis"},{"key":"2814_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.934076","volume":"12","author":"C Zhou","year":"2022","unstructured":"Zhou C, et al. Regulation, genomics, and clinical characteristics of cuproptosis regulators in pan-cancer. Front Oncol. 2022;12: 934076.","journal-title":"Front Oncol"},{"key":"2814_CR14","doi-asserted-by":"publisher","first-page":"1410431","DOI":"10.3389\/fnut.2024.1410431","volume":"11","author":"L Qin","year":"2024","unstructured":"Qin L, et al. Identification of potential biomarkers of cuproptosis in cerebral ischemia. Front Nutr. 2024;11:1410431.","journal-title":"Front Nutr"},{"key":"2814_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.947372","volume":"13","author":"L Deng","year":"2022","unstructured":"Deng L, et al. Comprehensive analyses of PDHA1 that serves as a predictive biomarker for immunotherapy response in cancer. Front Pharmacol. 2022;13: 947372.","journal-title":"Front Pharmacol"},{"key":"2814_CR16","doi-asserted-by":"publisher","first-page":"1136991","DOI":"10.3389\/fimmu.2023.1136991","volume":"14","author":"L Liu","year":"2023","unstructured":"Liu L, et al. Machine learning-based solution reveals cuproptosis features in inflammatory bowel disease. Front Immunol. 2023;14:1136991.","journal-title":"Front Immunol"},{"issue":"1","key":"2814_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13062-023-00358-w","volume":"18","author":"Y Chen","year":"2023","unstructured":"Chen Y, et al. Identification of a prognostic cuproptosis-related signature in hepatocellular carcinoma. Biol Direct. 2023;18(1):4.","journal-title":"Biol Direct"},{"issue":"12","key":"2814_CR18","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1007\/s00109-016-1475-3","volume":"94","author":"S Qie","year":"2016","unstructured":"Qie S, Diehl JA. Cyclin D1, cancer progression, and opportunities in cancer treatment. J Mol Med (Berl). 2016;94(12):1313\u201326.","journal-title":"J Mol Med (Berl)"},{"issue":"24","key":"2814_CR19","doi-asserted-by":"publisher","first-page":"16615","DOI":"10.1074\/jbc.R114.563148","volume":"289","author":"MS Patel","year":"2014","unstructured":"Patel MS, et al. The pyruvate dehydrogenase complexes: structure-based function and regulation. J Biol Chem. 2014;289(24):16615\u201323.","journal-title":"J Biol Chem"},{"issue":"1","key":"2814_CR20","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41698-024-00724-5","volume":"8","author":"J Chen","year":"2024","unstructured":"Chen J, et al. RNF4 mediated degradation of PDHA1 promotes colorectal cancer metabolism and metastasis. NPJ Precis Oncol. 2024;8(1):258.","journal-title":"NPJ Precis Oncol"},{"issue":"1","key":"2814_CR21","doi-asserted-by":"publisher","first-page":"4927","DOI":"10.1038\/s41598-023-32195-2","volume":"13","author":"J Jiang","year":"2023","unstructured":"Jiang J, et al. Artificial intelligence reveals dysregulation of osteosarcoma and cuproptosis-related biomarkers, PDHA1, CDKN2A and neutrophils. Sci Rep. 2023;13(1):4927.","journal-title":"Sci Rep"},{"key":"2814_CR22","doi-asserted-by":"publisher","first-page":"31146","DOI":"10.1038\/srep31146","volume":"6","author":"T Golias","year":"2016","unstructured":"Golias T, et al. Hypoxic repression of pyruvate dehydrogenase activity is necessary for metabolic reprogramming and growth of model tumours. Sci Rep. 2016;6:31146.","journal-title":"Sci Rep"},{"issue":"3","key":"2814_CR23","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.prp.2018.12.038","volume":"215","author":"L Song","year":"2019","unstructured":"Song L, et al. Low expression of PDHA1 predicts poor prognosis in gastric cancer. Pathol Res Pract. 2019;215(3):478\u201382.","journal-title":"Pathol Res Pract"},{"issue":"7","key":"2814_CR24","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","volume":"7","author":"T Farge","year":"2017","unstructured":"Farge T, et al. Chemotherapy-resistant human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism. Cancer Discov. 2017;7(7):716\u201335.","journal-title":"Cancer Discov"},{"issue":"35","key":"2814_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202404971","volume":"36","author":"S Lu","year":"2024","unstructured":"Lu S, Li Y, Yu Y. Glutathione-scavenging celastrol-Cu nanoparticles induce self-amplified cuproptosis for augmented cancer immunotherapy. Adv Mater. 2024;36(35): e2404971.","journal-title":"Adv Mater"},{"issue":"7","key":"2814_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202006892","volume":"33","author":"LH Fu","year":"2021","unstructured":"Fu LH, et al. Nanocatalytic theranostics with glutathione depletion and enhanced reactive oxygen species generation for efficient cancer therapy. Adv Mater. 2021;33(7): e2006892.","journal-title":"Adv Mater"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02814-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-02814-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02814-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T04:37:07Z","timestamp":1749530227000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-02814-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2814"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-02814-7","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,10]]},"assertion":[{"value":"20 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the Ethic Committee of Anhui Provincial Children\u2019s Hospital. No patient was involved in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors have declared no conflicts of interest in this work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1044"}}